Invention Grant
- Patent Title: Nicotinic attenuation of CNS inflammation and autoimmunity
- Patent Title (中): CNS炎症和自身免疫的烟碱性衰减
-
Application No.: US13063713Application Date: 2009-09-11
-
Publication No.: US08841329B2Publication Date: 2014-09-23
- Inventor: Fu-Dong Shi , Ronald J. Lukas , Timothy Vollmer
- Applicant: Fu-Dong Shi , Ronald J. Lukas , Timothy Vollmer
- Applicant Address: US AZ Phoenix
- Assignee: Dignity Health
- Current Assignee: Dignity Health
- Current Assignee Address: US AZ Phoenix
- Agency: Nixon Peabody LLP
- Agent Sean D. Senn
- International Application: PCT/US2009/056671 WO 20090911
- International Announcement: WO2010/030887 WO 20100318
- Main IPC: A61K31/44
- IPC: A61K31/44 ; A61K31/00 ; A61K31/685 ; A61K31/465 ; A61K45/06 ; A61K31/70
Abstract:
The present invention relates to methods of treating and/or ameliorating the severity of inflammation and autoimmunity in the central nervous system (CNS). In one embodiment, the present invention provides a method of treating multiple sclerosis by administering a therapeutically effective dosage of nicotine, or a pharmaceutical equivalent, analog, derivative, or salt thereof.
Public/Granted literature
- US20120322832A1 NICOTINIC ATTENUATION OF CNS INFLAMMATION AND AUTOIMMUNITY Public/Granted day:2012-12-20
Information query
